PCSA icon

Processa Pharmaceuticals
PCSA

Overview Fund Trends Analyst Outlook Journalist POV

17 hedge funds and large institutions have $3.22M invested in Processa Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

50% less capital invested

Capital invested by funds: $6.47M → $3.22M (-$3.25M)

Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$8.83K
2
+$4.36K
3
+$2.41K

Top Sellers

1
-$524K
2
-$359K
3
-$20K
4
VCA
Verdence Capital Advisors
Maryland
-$10K
5
BlackRock
BlackRock
New York
-$4.25K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.13M
2
$915K
3
$214K
4
$195K
5
$180K
6
$139K
7
$125K
8
$98K
9
$87K
10
$69K
11
$46K
12
$9K
13
$9K
14
$5K
15
$3K
16
$3K
17
–
18
–